Wasn’t it exciting as a kid when one of your favorite TV shows would have a special multi-episode arc full of guest stars? Well, the same thing has been happening in the U.S. Senate this year, as the Finance Committee takes on drug pricing. They’ve held several hearings in which
Next week, Intouch's own Justin Chase, EVP of Innovation and Media, will participate in a panel discussion on the subject when the DTC National Conference convenes in Boston. Read on to learn more.
This POV, compiled and produced by the Intouch team who attended this year’s SXSW, brings all our insights about what pharma marketers need to keep in mind this year -- and beyond -- together in one place!
Each year, Intouch sleuths South by Southwest, talking to experts, sharing insights, and getting inspired by the most creative minds in the world. On the ground, we debrief, connect the dots, and distill our findings to the themes and actions that will mean most to our teams and clients.
The Finance Committee of the U.S. Senate held two hearings – one in January and one in February -- on “Drug Pricing in America: A Prescription for Change.” As we’ve seen them unfold, they’ve been reminders of ongoing tensions with the industry, and a harbinger of what may be on the horizon for pharma manufacturers.
Fake news is everywhere — not just in the political realm. Accuracy is more important than ever, particularly with respect to conveying health information. How is your brand handling the challenge?
TL;DR: Authenticity is a popular 21st-century marketing buzzword. But when you pick apart what’s really behind that, you find new opportunities for pharma marketers. Authenticity, transparency, humanity, vulnerability – there are a lot of ways to describe what the public increasingly wants from brands. But simply put: they want
On November 20, 2018, the FDA published a Request for Comments about a proposed framework for regulating software applications (“apps”) disseminated by or on behalf of drug sponsors for use with one or more of their prescription drug products. This Intouch POV sets forth the scope of the proposed framework – what is and is not included, provides an overview of the proposed framework itself, and delivers recommendations for pharmaceutical companies involved in developing health-related apps.
As patients’ lives stretch for decades longer, a host of new considerations appear. What are your patients worried about for this new year… and for their years and decades ahead? Read on to learn about what questions to ask and how to help patients live better longer.
Patient support services programs have become common in the pharmaceutical industry, yet government scrutiny has left some pharma companies wondering what to do with these programs in the future. This POV lays out recommendations from overall business, compliance, legal, and regulatory viewpoints.